Sofinnova Investments’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-120,632
Closed -$1.61M 63
2024
Q3
$1.61M Sell
120,632
-11,457
-9% -$153K 0.13% 50
2024
Q2
$1.32M Buy
132,089
+89,078
+207% +$888K 0.07% 61
2024
Q1
$512K Buy
+43,011
New +$512K 0.03% 61